Elaine Riddell is a growth activist who believes that breakthrough potential exists in every company. She unlocks potential by anticipating the market disruptions that will influence client priorities and spending and then building organizational confidence to deliver the new value. As a CEO, over 15 years (NOPWorld Health, a unit of UBM, TNS Healthcare, Kantar Health), she is recognized for transforming mature, stagnant, global data, analytics, and insights firms into high-performing, scalable market-leaders with sustained, profitable revenue growth at three-times the market rate. Elaine's playbook also draws on her experience at Abbott Labs (now AbbVie), a top 10 Pharmaceutical company, and IMS Health (now IQVIA), the leading multinational health information and technology firm. Her composite of experience, which focuses on customer-centric innovation, strategic M&A, and building performance-driven cultures, forms the foundation for her growth advisory, serving founder/CEOs and Private Equity firms, as well as her M&A-related work. Today, Elaine is a Managing Director with Oaklins DeSilva+Phillips, a leading investment bank for the marketing and media services sectors.